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Abstract
Type III secretion (T3S) is an essential virulence factor used by Gram-negative pathogenic bacteria to deliver effector
proteins into the host cell to establish and maintain an intracellular infection. Chlamydia is known to use T3S to facilitate
invasion of host cells but many proteins in the system remain uncharacterized. The C. trachomatis protein CT584 has
previously been implicated in T3S. Thus, we analyzed the CT584 ortholog in C. pneumoniae (Cpn0803) and found that it
associates with known T3S proteins including the needle-filament protein (CdsF), the ATPase (CdsN), and the C-ring protein
(CdsQ). Using membrane lipid strips, Cpn0803 interacted with phosphatidic acid and phosphatidylinositol, suggesting that
Cpn0803 may associate with host cells. Crystallographic analysis revealed a unique structure of Cpn0803 with a
hydrophobic pocket buried within the dimerization interface that may be important for binding small molecules. Also, the
binding domains on Cpn0803 for CdsN, CdsQ, and CdsF were identified using Pepscan epitope mapping. Collectively, these
data suggest that Cpn0803 plays a role in T3S.
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Introduction
Chlamydia pneumoniae is an obligate, intracellular Gram-negative
bacterium associated with pneumonia and bronchitis. Members of
the Chlamydia genus all share a unique, biphasic life cycle initiated
by attachment of the metabolically quiescent elementary body
(EB) to a host cell. The remaining intracellular portion of the life-
cycle takes place within a plasma-membrane derived vacuole
known as an inclusion. Once inside the inclusion, EBs transform
into metabolically active reticulate bodies (RB) that becomes
associated with the inclusion membrane. Interaction with the
inclusion membrane allows RBs to communicate with the host cell
via T3S, permitting Chlamydia to commandeer host cell pathways
to acquire lipids, cholesterol, and other nutrients crucial for growth
and replication [1–3]. RB replication results in expansion of the
inclusion until an unknown stimulus signals non-infectious RBs to
transform into infectious EBs which exit the host cell either by cell
lysis or a packaged released mechanism termed extrusion, leaving
the host cell intact [4].
T3S is a virulence mechanism used by several Gram-negative
bacteria including Yersinia, Salmonella, Pseudomonas and E. coli to
inject effector proteins from the bacterial cytosol into the host cell
cytoplasm. The type III secretion system (T3SS) translocates
effectors through the inner membrane, periplasmic space, and
outer membrane in a single-step using a syringe-like apparatus
known as an injectisome [5–7]. This apparatus is activated
upon host cell-contact, possibly through interaction of the T3S
injectisome with cholesterol and sphingolipid rich microdomains,
termed lipid rafts, in the host cell membrane [8,9]. Insertion of
hydrophobic translocator proteins into host cell membranes is
thought to be dependent on lipid-rafts since in the absence of
cholesterol, translocators do not form pores and lyse artificial
membranes [10]. The needle-filament protein YscF (Yersiniae)
extends from the bacterial outer-membrane and houses the
needle-tip complex containing the sensor protein and possibly
the translocators [11]. The hierarchy of effector secretion at the
inner membrane is thought to be controlled by T3S ATPases.
The T3S ATPases (YscN orthologs) function at the inner
membrane, interacting with T3S effector proteins to dissociate
them from their cognate chaperones and allow effector passage
through the injectisome [12]. Another protein that exists in both
the soluble and insoluble fractions of the T3S system is the C-
ring protein (YscQ orthologs), which may function as a platform
to recognize effector/chaperone complexes, subsequently shut-
tling them to the inner membrane ATPase [13,14]. The needle-
tip complex, located at the tip of the T3S injectisome, is crucial
for sensing host-cell contact and initiating secretion [15]. Needle-
tip proteins first recognize cell contact and act as an extracellular
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membrane [16,17]. Crystallographic analysis of needle tip
proteins revealed a dumbbell-like structure with two globular
domains on either end of a ‘‘grip’’ formed by a conserved coiled-
coil motif [18]. Based on comparisons of biophysical properties
to other tip proteins, CT584 has been implicated as the needle
tip protein of C. trachomatis [19]. At this time, nothing is known
about the structure or function of Chlamydial needle tip proteins.
Here, we present data demonstrating that Cpn0803 (CT584
ortholog) from C. pneumoniae interacts with several T3S
components including the needle filament protein, the ATPase
and the C-ring protein. We also mapped the regions of Cpn0803
responsible for mediating these protein interactions. Structure
determination of Cpn0803 revealed a unique overall fold with no
structural similarity on the DALI server. Taken together, this
data suggests that Cpn0803 plays a role in C. pneumoniae type III
secretion.
Results
Cpn0803 interacts with T3S proteins
To explore whether Cpn0803 interacts with other T3S proteins,
we used ELISA and GST pull-down assays to evaluate possible
protein interactions. First, GST-CdsN, GST-CdsQ and GST-
CdsF were immobilized on glutathione plates, reacted against His-
Cpn0803, and monitored using a colorimetric assay to evaluate
possible protein interactions. Cpn0803 interacted with GST-
CdsN, GST-CdsQ and GST-CdsF with absorbance values
corresponding to 0.386.008, 0.416.006 and 0.366.01 absor-
bance units, respectively, that were significantly higher than
background levels (Figure 1A). As a positive control, we
demonstrated that GST-Cpn0803 interacted with His-Cpn0803
with an absorbance of 0.456.032. We also included a second
positive control between GST-Lcrh-2 and His-CopN (absorbance
of 0.616.065), which have been shown to interact in previous
Figure 1. Cpn0803 interacts with type III secretion components in vitro. A. A glutathione plate assay was applied to screen for interactions of
Cpn0803 between either CdsN, CdsQ or CdsF. His-Cpn0803 was applied to GST-CdsN, -CdsQ and -CdsF immobilized on glutathione plates, washed
three times with PBS, and monitored using a colorimetric assay. Data is represented on the graph as the mean 6 standard deviation for each
interaction. A significant interaction was considered to be two standard deviations above the negative control (GST alone against Cpn0803). As a
positive control, we screened GST-Cpn0803 against His-Cpn0803, as well as GST-Lcrh-2 against His-CopN. Cpn0803 interacted significantly with CdsN,
CdsQ, CdsF, and Cpn0803. while it did not interact with GST alone. GST-Lcrh-2 and His-CopN also had a significant interaction. B. We applied GST pull-
down assays to corroborate the interactions found with the glutathione plate assay. GST-CdsN, -CdsQ, –CdsF or GST alone immobilized on
glutathione beads were incubated with an E. coli lysate over-expressing His-Cpn0803 and washed with 500 mM NaCl. GST-CdsN, -CdsQ, and CdsF co-
purified with Cpn0803 under 500 mM NaCl conditions while GST alone did not.
doi:10.1371/journal.pone.0030220.g001
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standard deviations above the negative control (GST alone), which
had an absorbance value of 0.0466.003. Next, CdsN, CdsF and
CdsQ immobilized on glutathione beads were mixed with E. coli
lysates containing His-Cpn0803. The beads were harvested by
centrifugation and analyzed for His-Cpn0803 protein by anti-his
Western blot. In each case, His-Cpn0803 co-purified with GST-
CdsN, GST-CdsF or GST-CdsQ under high (500 mM) NaCl
conditions, suggesting that the interaction is specific (Figure 1B).
GST alone did not co-purify with Cpn0803 under any condition.
To corroborate the in vitro GST pull-down assays, we used
recombinant GST-CdsN, GST-CdsQ and GST-CdsF to pull-
down native Cpn0803 from an EB lysate (Figure 2). We found that
GST-CdsN, -CdsQ and -CdsF co-purified with native Cpn0803
from an EB lysate, suggesting that these proteins interact in vivo.
As a positive control, GST-Cpn0803 co-purified with native
Cpn0803 from an EB lysate while GST alone, as a negative
control, did not.
Structure of Cpn0803
The crystal structure of full-length Cpn0803 was determined by
SAD phasing of an anomalous data set collected from SeMet
derivatized protein (Figure 3). Cpn0803 crystallized in the
hexagonal space group P63, with two monomers in the asymmetric
unit. The final model was refined to R and Rfree values of 17.58
and 20.85%, respectively. Cpn0803 is 184 amino acids in length,
with the final model spanning residues 8–182 in chain A and
residues 8–183 in chain B. A complete list of X-ray diffraction data
and model refinement statistics can be found in Table 1.
The N-terminal 97 residues of the Cpn0803 monomer
assembled into a 4-helix bundle in which the fourth helix is bent
by a proline at position 87 (Figure 3). A short, five amino acid
loop joins the N-terminal helical domain to a 3-stranded anti-
parallel b-sheet. This b-sheet has one surface exposed to the
solvent while the other is flanked by three a-helices. Helices a6
and a8 run anti-parallel to one another and are joined by a short,
two turn helix (a7) sitting perpendicular to both which forms a
‘ ’s h a p e dm o t i f .
PISA is a software package able to predict the oligomeric
structure of a protein based on crystal contacts [21]. PISA analysis
suggested the biologically active unit of Cpn0803 to be a hexamer
formed by a trimer of dimers (Figure 4). In the crystal structure,
Cpn0803 forms a dimer mediated primarily by the C-terminal 3-
helix motif. This interface involves 68 residues from each
monomer and buries 6, 430 A ˚ 2, corresponding to approximately
35% of the total surface area of the complex. Helices a6 and a8
from either monomer associate to form a 4-helix bundle capped
on either end by a7. This interaction is stabilized through many
hydrophobic interactions, extensive hydrogen bonding and a
number of salt bridges. In the N-terminal domain, a total of 21
residues from a5 and the loop region joining b2 and b3 form
extensive interactions with two symmetry-mates in the crystal
packing that result in the formation of a trimer, burying an
additional 3, 867 A ˚ 2.
Dimerization of Cpn0803 forms a cone-shaped hydrophobic
pocket between the two 3-stranded b-sheets and is closed off at the
‘top’ by a6 from both chains A and B (Figure 5). This pocket is
lined almost entirely with hydrophobic residues and is stoppered at
the ‘bottom’ by F129 which forms a p-stacking interaction with its
counterpart from the second monomer. Five polar residues lie on
either side of the pocket, however, it appears that they are within
close enough proximity to form a network and satisfy the
hydrogen-bonding potential of their polar atoms as no ordered
water molecules were observed within this hydrophobic cavity.
Specifically the hydrogen-bond distances of T138–T133, T133–
N119, N119–S106, and S106–HB144 are 3.4, 2.8, 2.5, and 2.7 A ˚
respectively. All but T128–T133 are within ideal hydrogen
bonding distance, and T128–T133 can still be considered a
stabilizing electrostatic interaction if not a true hydrogen-bond.
The pocket is approximately 15 A ˚ in its longest dimension and has
a volume of ,211.3 A ˚ 3 as calculated by the CASTp server [22].
Cpn0803 interacts with host cell lipids
The presence of a hydrophobic pocket in Cpn0803 suggests that
it may have small molecule binding partners. To explore whether
Cpn0803 interacted with lipid components of the cell membrane,
Figure 2. Cpn0803 interacts with type III secretion components in vivo. C. pneumoniae EB lysates were incubated with recombinant GST-
CdsN, -CdsF, -CdsQ or -Cpn0803. Glutathione agarose beads were incubated with the lysates overnight, collected, and washed with 500 mM NaCl.
The protein on the beads was analyzed by SDS PAGE and Western blot with anti-Cpn0803 antibody. Native Cpn0803 co-purified with GST-CdsN,
-CdsF, and -CdsQ. As a positive control, Cpn0803 also co-purified with GST-Cpn0803, but not with GST alone.
doi:10.1371/journal.pone.0030220.g002
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strips which contain small amounts of purified lipids immobilized
on the surface of the strips. A positive interaction was detected
by anti-His Western blot after incubation of His-Cpn0803
with the strips (Figure 6). These strips were used to analyze
potential interactions with each of the following membrane
components: triglycerides, diacylglycerol, phosphatidic acid,
phosphatidylserine, phosphatidylethanolamine, phosphatidylcho-
line, phosphatidylglycerol, cardiolipin, phosphatidylinositol,
PtdIns(4)P, PtdIns(4,5)P2, PtdIns(3,4,5)P3, cholesterol, sphingo-
myelin, and sulfatide. Cpn0803 interacted with two of the 15 lipid
components evaluated, viz. phosphatidic acid (PA) and phospha-
tidylinositol (PI). His-CdsL (the T3S ATPase tethering protein and
negative regulator) was used as a negative control and did not
react with any of the lipid components.
Cpn0803 exists as a hexamer in solution
To explore whether Cpn0803 formed higher-ordered struc-
tures, we analyzed purified recombinant Cpn0803 using size-
exclusion chromatography (Figure 7). Prior to performing gel
chromatography, the column was standardized using the LMW
and HMW gel filtration standard kit. The elution volume of the
protein standards are shown on the x-axis. Cpn0803 eluted as a
predominant peak corresponding to a hexamer, with a smaller
peak corresponding to a dimer (Figure 7A). Both peaks were
shown to contain Cpn0803 as determined by anti-His Western
blot (Figure 7B).
Mapping of protein binding domains on Cpn0803
Having shown that Cpn0803 interacts with CdsN, CdsQ, and
CdsF, we next mapped the Cpn0803 binding surfaces for these
proteins. We used Pepscan epitope mapping for this purpose,
as has been described previously [23,24]. This method can
identify protein binding domains in Cpn0803 by screening
binding partners against a library of 13 amino acid Cpn0803
peptides. Thus, an overlapping peptide library of Cpn0803 was
synthesized and incubated with GST-CdsN, His-CdsQ, or His-
CdsF (Figure 8). Pepscan epitope mapping revealed distinct
binding domains on Cpn0803 for CdsN, CdsQ, and CdsF.
Specifically, CdsQ binding was localized to a surface correspond-
ing to residues QKNPVGEKN (amino acids 153–161) in the C-
terminal region (Figure 8). The CdsN binding surface corresponded
toresiduesLKRIFATPIGYTTFR(amino acids22–36) (Figure8)at
the N-terminus, and the CdsF binding surface corresponded to
residues LTQQERIFLNRARVDGQE (amino acids 109–129).
Random peptides sequences from Cpn0803, ranging from 15–30
amino acids in length, were used as negative controls and did not
interact with CdsN, CdsQ, or CdsFin the assay. To corroborate the
Pepscan epitope mapping, we cloned and expressed fragments of
Cpn0803 containing the CdsQ and CdsN interacting regions fused
to GST and performed GST pull-down assays against His-CdsQ
and His-CdsN (Figure 9). GST-Cpn08031–50, containing the CdsN
binding domain, co-purified with His-CdsN under high salt
conditions. GST-Cpn0803120–180, containing the CdsQ binding
domain, co-purified with His-CdsQ under high salt conditions.
GST-Cpn08031–50, which does not contain the CdsQ binding
domains, did not co-purify with CdsQ under any conditions. GST-
Figure 3. Stereo image of Cpn0803 monomer and dimer. The
structure of full-length Cpn0803 was determined by SAD phasing of an
anomalous data set collected from crystals of SeMet derivatized protein.
The overall structure of Cpn0803 has a unique fold and no structural
orthologs on the DALI server. A. Cartoon representation of the Cpn0803
monomer. Secondary structure elements are colored as follows; a-
helices in blue and b-strands in red. B. Cartoon representation of the
Cpn0803 dimer colored by chain.
doi:10.1371/journal.pone.0030220.g003
Table 1. Data Collection and Model Refinement Statistics.
SeMet Native
Data collection
Space group P63 P63
Cell parameters
a,b,c (A ˚) 85.28, 85.28, 97.83 86.39, 86.39, 99.59
a, b, c (u) 90, 90, 120 90, 90, 120
Molecules in ASU 2 2
Resolution (A ˚)
a 50.0 – 2.30 50 – 2.00
Unique reflections 35, 361 28, 547
Redundancy
a 4.4 (4.5) 9.7 (9.2)
Completeness (%)
a 100.0(100.0) 100.0 (100.0)
I/s(I)
a 10.75 (2.15) 23.06 (4.10)
Rmerge (%)
a 12.1 (72.8) 9.1 (66.9)
Wilson B - 26.19
Model refinement
Resolution (A ˚)









Lengths (A ˚) 0.009
Angles (u) 1.233
Average B Factor (A ˚2) 36.79
PDB Accession Code 3Q9D
aStatistics for the highest resolution shell are shown in parentheses.
doi:10.1371/journal.pone.0030220.t001
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30220Figure 4. Stereo image of a predicted Cpn0803 hexamer colored by chain. We evaluated Cpn0803 for its ability to form multimers by
analysis with the PISA server. Based on crystal contacts and buried surface area, the biologically active unit of Cpn0803 was predicted to be a hexamer
formed by a trimer of dimers. The individual monomeric units are shown in different colours.
doi:10.1371/journal.pone.0030220.g004
Figure 5. Stereo image of the hydrophobic pocket in Cpn0803. Dimerization of Cpn0803 results in the formation of a cone-shaped
hydrophobic pocket between the two 3-stranded b-sheets, closed off at the ‘top’ by a-6 from both chains A and B, and stoppered at the ‘bottom’ by
F129. The amino acid residues lining the interior of the pocket are represented in stick form.
doi:10.1371/journal.pone.0030220.g005
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did not co-purify with CdsN under any conditions.
Discussion
Although C. pneumoniae contains a functional T3SS, the
identification and function of several key proteins of the apparatus
have not been elucidated. In this report, we characterized a novel
T3S-associated protein Cpn0803 in C. pneumoniae, demonstrating
interactions with several key proteins of the T3SS. Using ELISA
and co-purification assays, we show that Cpn0803 interacts with
the ATPase CdsN, the needle filament protein CdsF, and the C-
ring protein CdsQ, and mapped their respective binding surfaces
using Pepscan mapping. We also show that Cpn0803 interacts
with eukaryotic cell membrane components PA and PI, suggesting
that Cpn0803 may associate with the host cell. The crystal
structure of Cpn0803 revealed a relatively large, isolated,
hydrophobic pocket within the dimer interface which may play
a role in binding small molecules such as PA and PI. These
observations suggest that Cpn0803 plays a role in T3S and may
associate with host-cell components.
Chlamydial T3S genes are encoded on ten operons scattered
throughout the genome [25]. The fact that Cpn0803 is not
encoded on one of the ten operons does not preclude the
possibility that Cpn0803 is a T3S effector or chaperone protein.
For example, TARP (a known T3S effector) is encoded separately
from the ten operons, not clustered with other T3S components.
Thus, we evaluated binding of Cpn0803 to T3S membrane and
peripheral-membrane components. T3S ATPases (YscN ortho-
logs) promote effector protein unfolding and secretion by
dissociating their cognate chaperones [12]. We have previously
shown that CdsN is the ATPase of the C. pneumoniae T3SS and
binds several effectors and chaperones, and the proposed C-ring
protein CdsQ [26]. Thus, the interaction between Cpn0803 and
CdsN is expected if Cpn0803 is secreted through the injectisome.
Spaeth et al. have recently presented data that supports a role for
CdsQ in C. trachomatis as a platform that organizes effector/
chaperone complexes at the basal body of the T3S apparatus [14].
Thus, the interaction of Cpn0803 with CdsQ is also consistent
with a possible role as a T3S effector or chaperone protein. The
interaction of Cpn0803 with the needle filament protein, CdsF,
suggests that Cpn0803 may function at the tip of the injectisome
and also supports its role in T3S. Taken together, these
observations suggest that Cpn0803 may function as an effector
or chaperone protein in Chlamydia T3S.
Cpn0803 crystallized in the hexagonal space group P63, with
two molecules in the asymmetric unit. A DALI search with the
structure of Cpn0803 yielded no significant hits to any proteins in
the current structural databases. Since CT584 (Cpn0803 ortholog)
was predicted to be the needle-tip protein in C. trachomatis based on
biophysical comparisons, we evaluated whether the structure of
Cpn0803 had any similarity to needle-tip orthologs. Cpn0803
shares very little amino acid orthology, secondary or tertiary
structure similarity with LcrV or IpaD. The only shared
characteristic between these three proteins is a 4-helix bundle at
the N-terminus. However, the central coiled-coil motif, which is
conserved in all needle-tip families, is absent from Cpn0803 [15].
Based on both PISA analysis of the crystal structure and size-
exclusion chromatography data of the recombinant protein,
Cpn0803 appears to exist in a dimer/hexamer equilibrium in
solution. Based on the crystal structure, the Cpn0803 hexamer is
globular and approximately 9.5 nm in diameter in its longest
dimension. However, the subunits are tightly packed and do not
form a pore. To function as an LcrV ortholog, the oligomeric state
of the needle-tip must permit passage of effector proteins through
the T3S apparatus [27]. Thus, the oligomeric state and crystal
structure of Cpn0803 does not support its role as the needle-tip
protein. However, it is possible that alternative oligomeric forms
exist which contain a pore, possibly after translocation through the
needle-complex.
We have shown that Cpn0803 interacts with both PA and PI.
The volume of the hydrophobic pocket within the dimerization
interface of the crystal structure of Cpn0803 is approximately
211.3 A ˚ 3, making this hydrophobic pocket large enough to bind a
small molecule. PA and PI are approximately 415 and 196 A ˚ 3,
respectively, indicating that PI, but not PA, could bind in the
pocket. Conformational changes in the structure of Cpn0803
induced by oligomerization could lead to changes in the size of the
hydrophobic pocket and facilitate binding of other small
molecules. It is possible that Cpn0803 undergoes conformational
changes upon binding PA or PI, and that this change is required
for Chlamydial infection of host cells and effector translocation.
Chlamydia is known to recruit proteins involved in phosphatidyli-
nositol-4-phosphate (PI4) metabolism to regulate the PI compo-
sition of the inclusion membrane, which is necessary for optimal
chlamydial development [28]. It is possible that Cpn0803 also
plays a role in regulating PI levels in the inclusion. Also,
phosphatidylinositol-3,4,5-P3 is synthesized at sites of chlamydial
entry upon host cell infection and may be important for actin
recruitment and activation of specific guanine nucleotide exchange
factors (GEFs) [29]. Cpn0803 may play a role in regulating these
GEFs within the host cell upon infection through its association
with PI. Thus, the Cpn0803 interaction with PI supports a possible
role as a T3S effector protein.
We employed Pepscan epitope mapping to determine the
Cpn0803 binding surfaces involved in the interaction with CdsN,
CdsQ, and CdsF [23,24]. We found that Cpn0803 possesses
specific surfaces mediating these interactions. The binding surface
for CdsN corresponded to residues 22–36 on the N-terminal
domain of Cpn0803. Based on the crystal structure, this surface
would be buried within the hexameric state of Cpn0803.
Therefore, cytoplasmic Cpn0803 likely interacts with CdsN as a
dimer. Partial unfolding of the dimer would further permit
secretion through the needle. CdsQ binding was mapped to a
Figure 6. Cpn0803 interacts with phosphatidylinositol and
phosphatidic acid. His-Cpn0803 was incubated with membrane lipid
strips containing purified eukaryotic membrane components and
visualized by anti-his antibody and ECL reagents. Cpn0803 interacted
with phosphatidylinositol and phosphatidic acid, but none of the other
molecules evaluated. His-CdsL, as a negative control, did not interact
with any lipid components.
doi:10.1371/journal.pone.0030220.g006
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the C-terminus. The separation between the N-terminal CdsN and
the C-terminal CdsQ binding surfaces may be important in the
‘‘hand-off’’ or transfer of Cpn0803 from the cargo transporter
protein CdsQ to the ATPase CdsN. The CdsF binding surface on
Cpn0803 corresponds to residues 109–129. This CdsF binding
surface is partially inaccessible in the hexameric Cpn0803 state,
but exposed in the dimer, suggesting that the Cpn0803 exists as a
dimer upon interaction with CdsF. The observation that the
interactions between Cpn0803 and CdsN/CdsF only occur with
dimeric Cpn0803 suggests that the hexameric form may represent
a stable cytoplasmic Cpn0803 structure, prior to inner membrane
recruitment and subsequent secretion. The oligomerization may
also be required for effector function in the host cell.
In the absence of a genetically tractable system for Chlamydia,
and the inability to knockout Cpn0803, the definitive role of
Figure 7. Cpn0803 exists in a hexameric and dimeric state in solution. A. Gel filtration chromatography was used to analyze purified His-
Cpn0803. We found two dominant peaks, one corresponding to a hexamer and one corresponding to a dimer. The elution volume of the protein
standards are shown on the x-axis. B. Peak fractions in the elution volumes were collected and analyzed by anti-His Western blot. Cpn0803 was
present in the peak fractions.
doi:10.1371/journal.pone.0030220.g007
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surfaces for key T3S proteins, such as the needle-filament protein
CdsF and the ATPase CdsN, supports the role of Cpn0803 in type
III secretion and possibly as an effector protein. However, the
crystal structure of Cpn0803 has very little similarity to LcrV or
IpaD orthologs and does not support its role as the needle-tip
protein. Whether Cpn0803 represents a novel class of needle-tip
proteins, or plays an alternative role in T3SS such as that of an
effector protein, requires further investigation.
Methods
Expression Plasmids
C. pneumoniae CWL029 (VR1310:ATCC) (GenBank accession #
AE001363) was used to isolate genomic DNA for cloning and
protein expression. Full length cdsN, cdsQ, cdsF, copN, lcrh-2, and
cpn0803 were amplified from CWL029 using AttB-containing
primers (Gateway; Invitrogen). Amplified products were cloned
into pDONR201 (Gateway; Invitrogen) to generate pENT vectors
which were then used in LR reactions (Gateway; Invitrogen) to
produce pEX vectors containing genes of interest. Either pEX17
(N terminal His-tag) or pEX15 (N terminal GST-tag) vectors were
used for protein expression. All constructs were confirmed by
DNA sequencing.
Purification of Recombinant Proteins
E. coli pellets containing over-expressed His- or GST-tagged
proteins were thawed on ice and sonicated using a Fischer
Scientific Sonic Dismembrator Model 100, followed by centrifu-
gation at 20,0006g for 40 minutes to remove insoluble material.
Supernatants containing His-tagged protein for use in GST pull-
down assays were stored at 4uC. GST tagged protein for use in
GST pull-down assays were bound to 300 mL of glutathione beads
overnight at 4uC, then blocked overnight in Tris Buffered Saline
with 0.1% Tween-20 and 4% BSA and stored at 4uC until use.
Purity was assessed using SDS-PAGE and Coomassie blue
staining. For His-tagged proteins, columns were washed with
increasing imidazole concentrations and proteins were eluted with
300 mM imidazole then dialyzed extensively against activity
buffer.
Figure 8. Pepscan mapping of the Cpn0803 binding regions shown in stereo. A. Pepscan epitope mapping against a Cpn0803 peptide
library was performed to determine the residues of Cpn0803 responsible for mediating its interactions with CdsN, CdsF and CdsQ. Recombinant
CdsN, CdsF and CdsQ was reacted against the Cpn0803 peptide library and monitored for the corresponding interacting regions. The corresponding
surfaces are color-coded as follows: CdsN in blue (residues 22–26), CdsF in purple (residues 109–128), and CdsQ in orange (residues 153–161).
doi:10.1371/journal.pone.0030220.g008
Figure 9. Corroboration of the Cpn0803 binding regions
identified by Pepscan using GST pull-downs. To corroborate
the Pepscan results, we expressed 50 amino acid fragments of Cpn0803
encompassing the CdsN and CdsQ binding domains and performed
GST pull-down assays against recombinant CdsN or CdsQ. GST-
Cpn0803120–180, containing the CdsQ binding domain, co-purified with
His-CdsQ under high salt conditions. GST-Cpn08031–50, which does not
contain the CdsQ binding domains, did not co-purify with CdsQ. GST-
Cpn0803120–180, which does not contain the CdsN binding domain, did
not co-purify with CdsN.
doi:10.1371/journal.pone.0030220.g009
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The glutathione-plate assay was performed using 96-well
Pierce Glutathione Coated Plates. Briefly, 200 mLo fal y s a t e
over-expressing a GST fusion protein was added to each well
and incubated at 4uC for 2 hours. Next, the lysate was removed
and the plate was washed with 200 mLo fP B Sf i v et i m e s .T h e
plate was blocked using 4% BSA in TBST for 2 hours at 4uC,
and then washed five times with 200 mL of PBS. Bacterial lysate
(300 mL) over-expressing a poly-histidine fused protein was
a d d e dt oe a c hw e l la n di n c u b a t e da t4 uC for 2 hours. To disrupt
non-specific interactions, the plate was washed eight times
with 500 mM NaCl, 0.1% Triton X-100, 50 mM TRIS-HCl
pH 7.5. After the wash, the wells were blocked with a 4% BSA
solution in TBST for 45 minutes at room temperature. Mouse-
anti-66His monoclonal antibody (1:1000 dilution in PBST)
was incubated for 45 minutes at room temperature. Bound
antibody was detected using a goat-anti-mouse horseradish
peroxidase conjugate (1:1000 dilution in PBST) and incubated
at room temperature for 45 minutes, followed by 100 mL
of 5 mg/mL OPD (o-Phenylenediamine) (Pierce) added to
each well and incubated at room temperature for 30 minutes
before reading the absorbance at 450 nm using a Bio-Tek
ELx800 plate reader. An interaction was considered positive if it
was two standard deviations above the negative control (GST
alone).
GST pull-downs
To examine the interaction of Cpn0803 with CdsN, CdsF, and
CdsQ, GST pull-down assays were performed as described
previously by Johnson et al, 2008, with the following modifications
[30]. Briefly, glutathione-agarose beads (30 mL) bound to 50 ng of
GST-tagged protein was used in the assay. The beads were
incubated overnight at 4uC with the E. coli lysate expressing the
His-tagged proteins. Beads were collected by centrifugation and
washed with 0.1% Triton X-100 and increasing concentrations of
NaCl to eliminate spurious protein interactions. The presence of
GST- and His-tagged proteins was confirmed by both Coomassie
blue and Western blot. GST alone bound to glutathione beads was
used as a negative control for the pull-down.
Production and affinity purification of rabbit polyclonal
antibody to Cpn0803
Hyper-immune rabbit antisera was raised against Cpn0803.
Briefly, His-Cpn0803 was expressed in E. coli BL21 and purified
on Ni nitrilotriacetic acid (NTA) agarose (Qiagen) according to
established procedures, and 500 mg was delivered to Cocalico
Biologicals, Inc. (Reamstown, PA), as a Coomassie-stained sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
gel slice. Three rounds of immunizations with the adjuvant
Titermax were employed. Immunoglobulin G (IgG) molecules
were precipitated from the hyper-immune antisera with 50%
saturated ammonium sulfate solution, resuspended in cold
phosphate-buffered saline (PBS), and dialyzed into PBS. Activated
CH-Sepharose beads (Sigma) were coupled with 30 mg of His-
Cpn0803and used to affinity purify the rabbit anti-Cpn0803 IgG.
Briefly, antibody was incubated with the His-Cpn0803-conjugated
beads overnight at 4uC with rocking and washed with ice-cold PBS
until the A280 was less than 0.02. Glycine (100 mM, pH 3.0) was
used to elute the rabbit anti-Cpn0803 IgG molecules in 1 ml
fractions into Eppendorf tubes containing 10 ml of 1.5 M Tris,
pH 8.8. Fractions were analyzed by probing Western blots
containing chlamydial EB lysate and an E. coli lysate containing
overexpressed His-Cpn0803.
Co-purification assays
Co-purification assays were performed essentially as described
previously to investigate the interaction of Cpn0803 from EBs with
GST-tagged T3S proteins [30]. Briefly, 72 hr postinfection, EBs
were purified on a discontinuous gradient and lysed in PBS
containing 1% Triton X-100 for 1 hr. EB lysates were pre-cleared
by microcentrifugation at 16, 0006 g for 30 min and then
incubated with GST-tagged proteins in PBS for 6 h. Gluathione
agarose beads (20 ml) were then added to each tube overnight.
Beads were collected by brief centrifugation, washed four times
with binding buffer containing 20 mM imidazole, and boiled in
26SDS-PAGE loading buffer. Co-purified Cpn0803 was detected
by Western blotting and ECL using hyper-immune guinea pig
anti-Cpn0803 antiserum.
Crystal structure of Cpn0803
All Cpn0803 crystals were grown at 18uC using the hanging-
drop vapour diffusion method. Equal volumes of Cpn0803
(3.0 mg/mL) in storage buffer (0.12 M potassium chloride,
0.2 M Tris pH 7.0) were mixed with crystallization solution
(0.2 M potassium nitrate, 20% w/v PEG 3350) and dehydrated
against 500 uL of 1.5 M ammonium sulfate. Cpn0803-SeMet
crystals were grown in the same manner by streak seeding with
native crystals and gradually increasing the concentration of
ammonium sulfate in the well solution to 2.0 M.
Native and SAD (SeMet) data sets were collected at 1.1 and
0.979 A ˚ wavelengths on beamlines 629 and 625 respectively of
the National Synchrotron Light Source at Brookhaven National
Laboratory. Data sets were processed and scaled with HKL2000
to 2.0 and 2.3 A ˚, respectively [31]. Of the 12 SeMet sites expected
based on primary sequence, 11 were located by AutoSol in the
anomalous data set. The Phenix software package was used to
calculate initial phase information to generate an experimental
map [32]. A preliminary model was built which was then used for
Molecular Replacement into the higher resolution, native data set
of Cpn0803 using AutoMR. Model building and structure
refinement of Cpn0803 was carried out through multiple iterations
of Phenix-Refine and manual manipulation in COOT until the
values of R and Rfree converged and geometry statistics reached
acceptable ranges [33,34]. Surface area calculations were
performed with the PDBe PISA server and volume calculations
were performed using Chimera and the CASTp server [21,22]. All
structural illustrations were generated with PyMol [35]. Crystal
structure similarity predictions were obtained using the DALI
server [36].
Size-exclusion chromatography
Purified Cpn0803 (250 ml) in gel filtration buffer (20 mM Tris
pH 7, 100 mM KCl, 5 mg/mL protein concentration) was
injected into a Superdex S200 10/300 GL gel filtration column
(Amersham Biosciences, Piscataway, New Jersey) at 0.1 mL/min.
The column was standardized using the LMW and HMW gel
filtration standard kit (GE Life Sciences). Elution fractions (1 mL)
were collected at a flow rate of 1 mL/min. Peak fractions were
examined by anti-His Western blot.
Membrane lipid strip assay
Membrane lipid strips were purchased from Echelon and
protein binding assays were performed according to the
manufacturer’s protocol. Briefly, lipid strips were blocked
overnight in blocking buffer (PBS, 0.1% Tween, 5% BSA) at
4uC. Next, His-Cpn0803 or His-CdsL (negative control) were
added to the lipid strips at a concentration of 0.5 mg/mL and
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discarded and the lipid strips were washed 5 times with PBS-T for
5 min. The lipid strips were then probed for bound His-tagged
protein using anti-His antibody (1:10000 dilution) and visualized
with ECL reagent.
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